Activity Description:

This presentation aims to equip medical professionals with the necessary knowledge and tools to effectively manage difficult-to-treat gram-negative infections. It will cover the recommendations provided in the IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.  This will encompass commonly encountered treatment questions and the corresponding suggested treatment approaches for 6 antimicrobial resistant gram-negative infections, including extended-spectrum β-lactamase producing Enterobacterales, AmpC β-lactamase producing Enterobacterales, Carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa with difficult-to-treat resistance, Carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia. This guidance applies to both adult and pediatric populations.

Target Audience: 

This course is designed for hospitalists, nurse practitioners, physician assistants, advance practice nurses, registered nurses, allied health professionals, physicians and residents.

Learning Objectives:

• Familiarize with the IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

• Understand the significance of antimicrobial resistance in gram-negative infections

• Identify six antimicrobial resistant gram-negative infections

• Explore the evidence-based treatment recommendations of antimicrobial resistant gram-negative infections

• Apply these newly developed guidelines with patient cases

Moderator:

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.